Dr Matthew Partridge
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
Latest articles by Dr Matthew Partridge
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published
-
How to invest in US small caps
For more than a decade, US small caps have lagged their larger counterparts. There are signs this is starting to change – here's how to stock up
By Dr Matthew Partridge Published
-
BT cuts revenue forecast – what's next for the telecoms giant?
BT has trimmed its sales forecast, but the overall outlook remains positive and big investors have bought in. Should you invest?
By Dr Matthew Partridge Published
-
Oil sector off the boil: what happens now?
Oil giants BP and Shell are starting to struggle amid a glut of black gold. And growth in demand looks likely to slow
By Dr Matthew Partridge Published
-
Invest in Hilton Foods: a tasty UK food supplier
Hilton Foods is a keenly priced opportunity in an unglamorous sector
By Dr Matthew Partridge Published
-
HSBC stocks jump – is its cost-cutting plan already paying off?
HSBC's reorganisation has left questions unanswered, but otherwise the banking sector is in robust health
By Dr Matthew Partridge Published
-
Shares in luxury goods companies take a hit – will they recover?
Luxury goods companies have run into trouble, and the odds of a rapid recovery have receded. What next?
By Dr Matthew Partridge Published
-
United Airlines set for growth – should you invest?
Airlines have rebounded well after Covid, but United Airlines can soar higher
By Dr Matthew Partridge Published
-
How to prepare your portfolio for the US election
There’s still all to play for in the US election race between Kamala Harris and Donald Trump. What will victory for either mean for investors?
By Dr Matthew Partridge Published
-
Nestlé is in trouble as it pushes prices up
Nestlé has pushed up prices for customers and now it's suffering the consequences, leaving a spotlight on its performance and shares
By Dr Matthew Partridge Published
-
How will the UK gambling sector be hit by the Budget?
There are concerns for the UK gambling sector in the lead-up to the Autumn Budget. What could be on the cards?
By Dr Matthew Partridge Published
-
HSBC returns to cost-cutting plan
HSBC is set to revamp its commercial banking division – but will it come at a cost?
By Dr Matthew Partridge Published
-
Israel conflict: the concerns of a wider war
Israel's raids into Lebanon have raised fears of a wider war
By Dr Matthew Partridge Published
-
Pfizer shares rise as US investor takes $1 billion stake
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic options appear limited
By Dr Matthew Partridge Published
-
Harworth doubles profit as revenue soars – should you buy?
Harworth, a specialist property developer, is well-aligned with government policies, with revenue expected to rise by over 50% this year, and a further 30% the year after.
By Dr Matthew Partridge Published
-
Middle East conflict: is an all-out war inevitable?
Events have taken an ominous turn in the Middle East after Iran’s attacks on Israel. Will Israel and its allies retaliate, and how bad can it get?
By Dr Matthew Partridge Last updated
-
Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
By Dr Matthew Partridge Published
-
Google's legal challenges – could it be broken up?
Google is fending off legal challenges from both the EU and the US. But would breaking it up actually work?
By Dr Matthew Partridge Published
-
The US election has witnessed more political violence, just how ugly could it get?
US Election Donald Trump is at the center of the US election yet again, but not for good reason. Will there be a peaceful handover of power in 2025?
By Dr Matthew Partridge Published
US Election -
Apple shares slide amid underwhelming demand for new iPhone
Apple shares fell last week after disappointing demand for the new iPhone 16 Pro. Can Apple depend on AI to give it a boost?
By Dr Matthew Partridge Published
-
Bitcoin miner Riot Platforms bleeds money – what happens now?
Riot Platforms struggles to make a profit and looks absurdly overvalued. Are troubles brewing?
By Dr Matthew Partridge Published
-
Shares in gambling group Entain rise
Shares in Entain rose by 5% after three years of the stock sliding. Is more luck on the cards for the gambling group?
By Dr Matthew Partridge Published
-
Michel Barnier is the new French PM – so, what now?
After a 'stolen election', Michel Barnier, former EU Brexit negotiator has been appointed as France's new prime minister. What does it mean for France?
By Dr Matthew Partridge Published
-
Takeover bid for Japan's 7-Eleven owner from Canadian chain
The Japanese operator of 7-Eleven convenience stores is being wooed by a Canadian peer. But securing a deal won’t be easy
By Dr Matthew Partridge Published